|
Mr. Rodriguez is a technology management strategist and business development executive with extensive experience in both the technological and business facets of the pharmaceutical, biotechnology and medical diagnostic industries. He has extensive experience in identifying technological opportunities, assessing their technological and commercial viability and positioning their application to maximize their competitive advantage. Mr. Rodriguez has held key marketing and business development positions at Enzon, Inc.(NASDAQ: ENZN), a drug delivery and recombinant engineered antibody company and Sienna Biotech, Inc. a medical diagnostic systems company that served as the basis for American Standard Inc.'s' Medical Products business unit. Mr. Rodriguez has also served as a consultant to a number of companies regarding strategic and business development related issues, including Principia Pharmaceutical Corporation (recently acquired by Human Genome Sciences, Inc. (NASDAQ: HGSI)) and Peprotech, Inc.; contributed to the publication, Winning in High Tech Markets (Harvard Business School Press) and is a Principal of Altira Capital & Consulting, LLC. Mr. Rodriguez has also negotiated and consummated numerous in-licensing and out-licensing agreements with major pharmaceutical companies as well as smaller biotech companies and universities including international agreements with Rhone-Poulenc Rorer and Bristol-Myers Squibb in the oncology field. | 